The Role of the CD28/B7 Interaction in the Regulation of NK Cell Responses during Infection with Toxoplasma gondii

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2285-2293

  Hunter, Christopher A ^a   Ellis Neyer, Lauri ^b,c   Gabriel, Katherine E ^c   Kennedy, Mary K ^d   Grabstein, Kenneth H ^e   Linsley, Peter S ^f   Remington, Jack S ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PALO ALTO MEDICAL FOUNDATION   (United States)

^d AMGEN INC   (United States)

^e GLAXOSMITHKLINE   (United States)

^f BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ANIMAL PARASITOSIS; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CBA MOUSE; FEMALE; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; PHYSIOLOGY; SARCOMA; TOXOPLASMA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; FEMALE; IMMUNOCONJUGATES; INJECTIONS, INTRAPERITONEAL; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MAST-CELL SARCOMA; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, SCID; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031091746     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
2. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiological antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
3. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
4. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62:2818.
5. Scharton-Kersten, T., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental Leishmaniasis. J. Immunol. 154:5320.
6. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J Immunol. 156:735.
7. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96:2578.
8. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503.
9. Biron, C. A., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485.
10. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. Interleukin 1β is required for the ability of IL-12 to induce production of IFN-γ by NK cells: a role for IL-1β in the T cell independent mechanism of resistance against intracellular pathogens. J. Immunol. 155:4347.
11. Bancroft, G. J., R. D. Schreiber, and E. R. Unanue. 1991. Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse. Immunol. Rev. 124:5.
12. Hunter, C. A., L. Bermudez, H. Beernink, W. Waegell, and J. S. Remington. 1995. Transforming growth factor-β inhibits interleukin-12-induced production of interferon-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T-cell independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25:994.
13. Bellone, G., M. Aste-Amezaga, G. Trinchieri, and U. Rodeck. 1995. Regulation of NK cell functions by TGF-β1. J. Immunol. 155:1066.
14. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
15. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, D. J. Lenschow, R. Stack, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1995. T cell costimulation through the CD28 receptor. Proc. Assoc. Am. Physicians 107:41.
16. Linsley, P. S. 1995. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation. J. Exp. Med. 182:289.
17. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065.
18. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
19. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production by human T cells. J. Exp. Med. 180:211.
20. Murphy, E., G. Terres, S. Macatonia, C.-S. Hsie, J. Mattson, L. Lanier, M. Wysocka, G. Trinchieri, K. Murphy, and A. O'Garra. 1994. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper cell clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:223.
21. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative NK cells. J. Immunol. 143:3183.
22. Nandi, D., J. A. Gross, and J. P. Allison. 1994. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152:3361.
23. Tacke, M., G. J. Clark, M. J. Dallman, and T. Hunig. 1995. Cellular distribution and costimulatory function of rat CD28. J. Immunol. 154:5121.
24. Azuma, M., M. Cayabyab, D. Buck, I. H, Phillips, and L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
25. Geldhof, A. B., G. Raes, M. Bakkus, S. Devos, K. Thielmans, and P. De Baetselier. 1995. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 55:2730.
26. Chambers, B. J., M. Salcedo, and H.-G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311.
27. Gazzinelli, R. T., E. Y. Denkers, and A. Sher. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect. Agents Dis. 2:139.
28. k haplotype. J. Immunol. 137:2991.
29. Sander, B., I. Hoiden, U. Andersson, E. Moller, and J. S. Abrams. 1993. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. J. Immunol. Methods 166:201.
30. Grabstein, K. H., J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M. A. Schoenborn, M. Ahdieh, L. Johnson, M. R. Alderson, J. D. Watson, D. M. Anderson, and J. G. Giri. 1994. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965.
31. Sher, A., I. P. Oswald, S. Hieny, and R. Gazzinelli. 1993. Toxoplasma gondii induces a T-independent IFN-γ response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-α. J. Immunol. 150:3982.
32. Wherry, J. C., R. D. Schreiber, and E. R. Unanue. 1991. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709.
33. Hunter, C. A., J. S. Abrams, M. H. Beaman, and J. S. Remington. 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect. Immun. 61:4038.
34. Su, H. C., R. Ishikawa, and C. A. Biron. 1993. Transforming growth factor-β expression and natural killer cell responses during virus infection of normal, nude, and SCID mice. J Immunol. 151:4874.
35. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. J. Immunol. 156:1138.
36. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
37. Haque, S., I. Khan, A. Haque, and L. Kasper. 1994. Impairment of the cellular immune response in acute murine toxoplasmosis: regulation of interleukin 2 production and macrophage-mediated effects. Infect. Immun. 62:2908.
38. Candolfi, E., C. A. Hunter, and J. S. Remington. 1995. Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavlin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751.
39. c subunits. J. Immunol. 156:1339.
40. Tagaya, Y., R. N. Bamford, A. P. DeFilippis, and T. A. Waldman. 1996. IL-15: a pleiotropic cytokine with diverse receptor/signalling pathways whose expression is controlled at multiple levels. Immunity 4:329.
41. Ferrini, S., B. Azzerone, and C. Jasmin. 1995. Is IL-15 a suitable candidate for cancer gene therapy? Gene Ther. 3:656.
42. Kennedy, M. K., and L. S. Park. 1996. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J. Clin. Immunol. 16:134.
43. Azuma, M., M. Cayabyab, J. H. Phillips, and L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150:2091.
44. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
45. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
46. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523.
47. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvi, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the TH1/TH2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
48. Nakajima, A., M. Azuma, S. Kodera, S. Nuriya, A. Terashi, M. Abe, S. Hirose, T. Shirai, H. Yagita, and K. Okumura. 1995. Preferential dependence of autoantibody production in murine lupus on CD86 co-stimulatory molecule. Eur. J. Immunol. 25:3060.
49. Wu, T., A. Y. C. Huang, E. M. Jaffee, H. I. Levitsky, and D. M. Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182:1415.
50. Mowat, A. M., and M. V. Felstein. 1987. Experimental studies of immunologically mediated enteropathy. II. Role of natural killer cells in the intestinal phase of murine graft-versus-host reaction. Immunology 61:179.
51. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3:171.
52. O'Toole, M., S. F. Wolf, C. O'Brien, N. Hubbard, and S. Herrmann. 1993. Effect of in vivo IL-12 administration on murine tumor cell growth. L. Immunol. 150: 294A (Abstr. 1679).
53. Tahara, H., L. Zitvogel, W. J. Siorkus, H. J. Zeh, T. G. McKinney, R. D. Schreiber, U. Gubler, P. D. Robbins, and M. T. Lotze. 1995. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154:6466.
54. Whiteside, T. L., and R. B. Herberman. 1995. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7:704.